T1和T2期胆囊癌外科治疗研究进展

doi:10.3877/cma.j.issn.1674-0793.2024.03.010

T1、T2期胆囊癌处于局部早中期，手术切除是首选治疗方法，通过制定合理的手术方案，多数患者预后良好。目前，国内外在Tis及T1a期胆囊癌治疗上已达成共识，但T1b、T2a、T2b期胆囊癌的治疗策略仍存在许多争议，尤其是在肝脏切除和淋巴结清扫范围上没有明确的共识。因此，外科医师应针对不同的患者，需要充分评估和预测，制定适合患者的最佳治疗方案，以获得更好的预后。

关键词: 胆囊肿瘤, TNM分期, 淋巴转移, 肝切除术

T1- and T2-stage gallbladder cancer belongs to early and middle stage, and surgical resection is the first choice of treatment. By formulating reasonable surgical methods, most patients have good prognosis. At present, there is consensus on the treatment of Tis and T1a patients at home and abroad, but there are still many disputes on the treatment strategy of T1b, T2a and T2b patients, especially on the scope of hepatectomy and lymph node dissection. Therefore, surgeons need to fully evaluate, predict, and formulate the optimal treatment plans for different patients to achieve better prognosis.

Key words: Gallbladder neoplasms, TNM stage, Lymphatic metastastasis, Hepatectomy

[1]	李奇为, 季福. 胆囊癌Nevin分期与AJCC分期的临床应用价值比较[J]. 中华普通外科杂志, 2009, 24(7): 521-524.
[2]	Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC Cancer Staging Manual: pancreas and hepatobiliary cancers[J]. Ann Surg Oncol, 2018, 25(4): 845-847.
[3]	李茂岚, 刘颖斌. 胆囊癌诊治进展[J]. 肝胆外科杂志, 2019, 27(5): 326-328.
[4]	钱昌林, 刘颖斌. TNM分期在胆囊癌根治性切除术中地位和作用[J]. 中国实用外科杂志, 2022, 42(9): 1046-1050.
[5]	Benson AB, D’Angelica MI, Abbott DE, et al. Guidelines insights: hepatobiliary cancers, Version 2.2019[J]. J Natl Compr Canc Netw, 2019, 17(4): 302-310.
[6]	Nagino M, Hirano S, Yoshitomi H, et al. Clinical practice guidelines for the management of biliary tract cancers 2019: the 3rd English edition[J]. J Hepatobiliary Pancreat Sci, 2021, 28(1): 26-54.
[7]	Kim BH, Kim SH, Song IS, et al. The appropriate surgical strategy for T1b gallbladder cancer incidentally diagnosed after a simple cholecystectomy[J]. Ann Hepatobiliary Pancreat Surg, 2019, 23(4): 327-333.
[8]	Yuza K, Sakata J, Prasoon P, et al. Long-term outcomes of surgical resection for T1b gallbladder cancer: An institutional evaluation[J]. BMC Cancer, 2020, 20(1): 20.
[9]	Lee SE, Jang JY, Lim CS, et al. Systematic review on the surgical treatment for T1 gallbladder cancer[J]. World J Gastroenterol, 2011, 17(2): 174-180.
[10]	Xu L, Tan H, Liu X, et al. Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database (2004 to 2013)[J]. Cancer Med, 2020, 9(11): 3668-3679.
[11]	Ren T, Li YS, Dang XY, et al. Prognostic significance of regional lymphadenectomy in T1b gallbladder cancer: results from 24 hospitals in China[J]. World J Gastrointest Surg, 2021, 13(2): 176-186.
[12]	吴昕, 洪涛, 李秉璐, 等. T2a期胆囊癌联合或不联合肝脏切除治疗的效果分析[J]. 中国普外基础与临床杂志, 2022, 29(11): 1458-1462.
[13]	Kang H, Choi YS, Suh SW, et al. Prognostic significance of tumor location in T2 gallbladder cancer: A systematic review and meta-analysis[J]. J Clin Med, 2021, 10(15): 3317.
[14]	Lee SE, Choi YS, Kim YH, et al. Prognostic significance of tumor location in T2 gallbladder cancer: A Korea Tumor Registry System Biliary Pancreas (KOTUS-BP) database analysis[J]. J Clin Med, 2020, 9(10): 3268.
[15]	Lafaro K, Blakely AM, Melstrom LG, et al. Prognostic impact of tumor location in resected gallbladder cancer: A national cohort analysis[J]. J Surg Oncol, 2020, 122(6): 1084-1093.
[16]	中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版)[J]. 中华外科杂志, 2020, 58(4): 243-251.
[17]	Chen M, Cao J, Xiang Y, et al. Hepatectomy strategy for T2 gallbladder cancer between segment Ⅳb and Ⅴ resection and wedge resection: A propensity score-matched study[J]. Surgery, 2021, 169(6): 1304-1311.
[18]	Zhang W, Huang Z, Wang WE, et al. Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T2 gallbladder cancer: A propensity-matched population-based study (2010 to 2015)[J]. Front Oncol, 2021, 11: 705299.
[19]	Lee W, Jeong CY, Jang JY, et al. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study[J]. Surgery, 2017, 162(3): 515-524.
[20]	Sternby Eilard M, Lundgren L, Cahlin C, et al. Surgical treatment for gallbladder cancer - a systematic literature review[J]. Scand J Gastroenterol, 2017, 52(5): 505-514.
[21]	Goetze TO, Paolucci V. Incidental T1b-T3 gallbladder carcinoma. Extended cholecystectomy as an underestimated prognostic factor-results of the German registry[J]. Chirurg, 2014, 85(2): 131-138.
[22]	Köhn N, Maubach J, Warschkow R, et al. High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: A population-based, propensity score adjusted analysis[J]. HPB (Oxford), 2018, 20(11): 1073-1081.
[23]	Goel M, Pandrowala S, Patel P, et al. Node positivity in T1b gallbladder cancer: A high volume centre experience[J]. Eur J Surg Oncol, 2022, 48(7): 1585-1589.
[24]	Wang Z, Li Y, Jiang W, et al. Simple cholecystectomy is adequate for patients with T1b gallbladder adenocarcinoma < 1 cm in diameter[J]. Front Oncol, 2019, 9: 409.
[25]	Shao J, Lu HC, Wu LQ, et al. Simple cholecystectomy is an adequate treatment for grade Ⅰ T1bN0M0 gallbladder carcinoma: evidence from 528 patients[J]. World J Gastroenterol, 2022, 28(31): 4431-4441.
[26]	Li G, Kim JH, Jung W, et al. Significance of hepatectomy in patients diagnosed with T2 gallbladder cancer[J]. Surg Laparosc Endosc Percutan Tech, 2020, 30(1): 35-39.
[27]	Toge K, Sakata J, Hirose Y, et al. Lymphatic spread of T2 gallbladder carcinoma: regional lymphadenectomy is required independent of tumor location[J]. Eur J Surg Oncol, 2019, 45(8): 1446-1452.
[28]	Shirai Y, Sakata J, Wakai T, et al. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes[J]. World J Surg Oncol, 2012, 10: 87.
[29]	Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition[J]. J Hepatobiliary Pancreat Sci, 2015, 22(3): 181-196.

[1]	刘哲魁, 马文星, 聂灵芝, 吴云桦, 单良, 王泽正. HALP评分联合术前检查预测老年胃癌淋巴结转移的价值[J]. 中华普通外科学文献(电子版), 2024, 18(03): 209-215.
[2]	刘炯, 彭乐, 马伟, 江斌. 鞘外解剖肝蒂技术治疗肝内胆管细胞癌的疗效评估[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 373-376.
[3]	达热拜·热达提, 刘林, 赵为民, 孟涛, 雷程, 金博, 毕建军, 李新宇, 王海江. 中低位直肠癌新辅助放化疗后侧方淋巴结清扫术的临床观察[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 415-418.
[4]	朱楠, 沈锋. 腹腔镜半肝切除术[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 367-367.
[5]	刘连新, 张树庚. 腹腔镜左半肝联合左尾状叶切除术[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 368-368.
[6]	唐浩, 梁平, 程千里, 徐小江, 曾凯, 文拨辉. 基于数字化微创技术对复杂性肝胆管结石患者胆道、肝静脉、门静脉解剖与变异情况及应用效果研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 291-294.
[7]	吴波, 郑永明, 杜世强. SPECT/CT及血清sTg水平预测甲状腺癌术后¹³¹I治疗患者淋巴结转移风险的价值分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 212-216.
[8]	陈政, 叶庆旺, 赵东波, 石鑫, 吴建强, 余德才. 定位针引导下腹腔镜精准局部肝切除应用探索[J]. 中华腔镜外科杂志(电子版), 2024, 17(02): 125-128.
[9]	钟造茂, 罗文超, 蔡满航, 陈显育, 钟跃思. 肝癌肝切除术后肝衰竭的危险因素分析及列线图模型构建[J]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 289-295.
[10]	陈志坚, 俞建达, 池小斌, 吕立志, 陈永标. 三维可视化技术在腹腔镜肝巨大肿瘤切除中的应用价值[J]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 302-307.
[11]	张燕, 许丁伟, 胡满琴, 李新成, 李翱, 黄洁. 胆囊癌免疫治疗的知识图谱可视化分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 319-327.
[12]	王礼光, 严庆, 廖珊, 符荣党, 陈焕伟. 微血管侵犯及手术切缘对肝细胞癌患者术后生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 151-157.
[13]	杨建彬, 陈建华, 张文华, 刘建东. 中心静脉压差值对腹腔镜肝细胞癌肝切除术中出血的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 158-162.
[14]	张婵, 吕瑶, 张小燕, 张鸣青. 不同时机局部神经阻滞在开腹肝切除中的镇痛效果比较[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 189-194.
[15]	蒋启红, 任勇军. 钆塞酸二钠增强MRI在评估肝功能的研究进展[J]. 中华消化病与影像杂志(电子版), 2024, 14(02): 183-187.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Progress in the surgical treatment of T1- and T2-stage gallbladder cancers

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Progress in the surgical treatment of T1- and T2-stage gallbladder cancers